Opentrons Labworks
Brooklyn, New York, United States · Artificial Intelligence, Biotechnology, Life Science · 500 employees
Opentrons Labworks, Inc. is a leader in lab automation and makers of accessible lab robotics. The company accelerates innovation in research and healthcare through its integrated lab platform, including business units Opentrons Robotics and Neochromosome. Opentrons has raised over $200 million in funding and achieved unicorn status based on its first- and second-generation robots, OT-One and OT-2.
Funding history
- Funding Round — $20.1M — Dec 2025
- Funding Round — $209.0M — Sep 2021
- Funding Round — $25.0M — Feb 2021
- Funding Round — $8.7M — Nov 2020
- Funding Round — $20.6M — Aug 2020
Recent signals
- Dec 05, 2025: Raised $20.1M
- Jan 27, 2025: Launched Opentrons Labworks, Inc. launches the Flex High-Throughput NGS Workstation to enhance genomics workflows. This cost-effective instrument streamlines NGS library prep, making hands-free processing of up to 96 samples a reality.
- Jul 18, 2023: Opentrons Hires Gautam Prabhu as CTO to Accelerate Automated Lab Robotics Engineering Solutions
- Sep 23, 2021: Raised $209.0M
- Feb 09, 2021: Raised $25.0M
- Nov 09, 2020: Raised $8.7M
- Aug 25, 2020: Raised $20.6M
- Nov 12, 2019: Raised $2.3M
See plans & pricing → Track Opentrons Labworks’s funding, hiring, and signals — with verified contacts — on Fundz.